Changes in Serum CXCL13 Levels Are Associated with Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment
Sara Cabrero-de las Heras,Xavier Hernandez-Yague,Andrea Gonzalez,Ferran Losa,Gemma Soler,Cristina Buges,Iosune Baraibar,Anna Esteve, Miguel Angel Pardo-Cea,Anne Hansen Ree,Neus Martinez-Bosch, Maria Nieva,Eva Musulen,Sebastian Meltzer, Tania Lobato, Carla Vendrell-Ayats,Cristina Queralt,Pilar Navarro,Clara Montagut, Ferran Grau-Leal, David Camacho,Raquel Legido,Nuria Mulet-Margalef,Eva Martinez-Balibrea Biomedicine & Pharmacotherapy（2024）
关键词
Colorectal cancer,Oxaliplatin,predictive biomarkers,Luminex,CXCL13,Tertiary Lymphoid Structures (TLS)
AI 理解论文
溯源树
样例
